Applera Corp--Celera Genomics (NYSE: CRA)
301 Merritt 7
Norwalk, CT 06851
http://www.celera.com
News
12/16/99: Buy Announcement
04/23/02: Sell Announcement
Buy Stats
On December 17, 1999 the Rule Breaker Portfolio bought 630 shares
of bioinformatics company Celera Genomics (NYSE: CRA). The cost was $79.50 per share plus an $8.00 commission.
For the full rationale behind this Rule Breaking purchase, please
see the
buy report.
ACTION # STOCK PRICE COMS'N TOTAL COST
BOUGHT 630 CRA $79.50 $8 $50,093.00
Sell Stats
On April 24, 2002, the Rule Breaker Portfolio sold all 1260 of its
shares (after a 2:1 stock split) in Celera Genomics, filled as 100
at $16.64 a share and 1160 at $16.30 a share, plus an $8 commission.
We lost 59% of our investment in Celera Genomics, compared to
a 23% loss in the S&P 500. For the rationale behind the sale,
please see the
sell report.
ACTION # STOCK PRICE COMS'N PROCEEDS
SOLD 100 CRA $16.64
SOLD 1160 CRA $16.30 $8 $20,564.00
